Spruce Biosciences Inc
NASDAQ:SPRB

Watchlist Manager
Spruce Biosciences Inc Logo
Spruce Biosciences Inc
NASDAQ:SPRB
Watchlist
Price: 84 USD 0.31% Market Closed
Market Cap: 89.9m USD

Intrinsic Value

The intrinsic value of one SPRB stock under the Base Case scenario is 116.42 USD. Compared to the current market price of 84 USD, Spruce Biosciences Inc is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SPRB Intrinsic Value
116.42 USD
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Spruce Biosciences Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about SPRB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SPRB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Spruce Biosciences Inc.

Explain Valuation
Compare SPRB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SPRB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Spruce Biosciences Inc

Current Assets 14.5m
Cash & Short-Term Investments 10.7m
Other Current Assets 3.8m
Non-Current Assets 797k
PP&E 735k
Other Non-Current Assets 62k
Current Liabilities 9.4m
Accounts Payable 1.4m
Accrued Liabilities 7.5m
Other Current Liabilities 539k
Non-Current Liabilities 500k
Other Non-Current Liabilities 500k
Efficiency

Free Cash Flow Analysis
Spruce Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Spruce Biosciences Inc

Revenue
697k USD
Operating Expenses
-50.2m USD
Operating Income
-49.5m USD
Other Expenses
1.6m USD
Net Income
-47.9m USD
Fundamental Scores

SPRB Profitability Score
Profitability Due Diligence

Spruce Biosciences Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
13/100
Profitability
Score

Spruce Biosciences Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

SPRB Solvency Score
Solvency Due Diligence

Spruce Biosciences Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
38/100
Solvency
Score

Spruce Biosciences Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SPRB Price Targets Summary
Spruce Biosciences Inc

Wall Street analysts forecast SPRB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRB is 213.69 USD with a low forecast of 161.6 USD and a high forecast of 271.95 USD.

Lowest
Price Target
161.6 USD
92% Upside
Average
Price Target
213.69 USD
154% Upside
Highest
Price Target
271.95 USD
224% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Spruce Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SPRB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SPRB Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SPRB stock?

The intrinsic value of one SPRB stock under the Base Case scenario is 116.42 USD.

Is SPRB stock undervalued or overvalued?

Compared to the current market price of 84 USD, Spruce Biosciences Inc is Undervalued by 28%.

Back to Top